Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 827 dose-ranging placebo-controlled phase 2 study in inadequately controlled asthma
NL-OMON34185Phase 2Active, not recruiting
- Sponsor
- Amgen
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of brodalumab, sponsored by Amgen. Started Aug 2011; status: active, not recruiting.
02
Drugs
brodalumab
Beyond the preview
Go deeper on NL-OMON34185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34185.